Viewing Study NCT01903928


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2026-01-13 @ 9:05 AM
Study NCT ID: NCT01903928
Status: COMPLETED
Last Update Posted: 2024-10-17
First Post: 2013-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell Transplant
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module